@jeremiah @levisan yeah, could be a vector that pharma is happy about, but i doubt that’s the leading factor, bc 1) most folks leading the charge on normalization of broader autistic and adhd communities are also advocating mainly a non-medical, non-pharma paradigm for how it’s treated, 2) autism in particular isn’t particularly suited for pharmaceutical interventions. adhd fits your bill a bit better.
@jeremiah @levisan i do think there’s prob a lot of folks experiencing adhd-like symptoms that have something else going on that’s causing some similar symptoms, and that the DSM framework for it needs updating, but how many of those folks are actually being diagnosed and treated w stimulant pharmaceuticals? no idea. but it’s not that easy for adults to get diagnosed in many places, from what i hear
